Akums Drugs and Pharma shares list at 7% premium over issue price

August 6, 2024

Akums Drugs and Pharmaceuticals’ shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subscribed 63.5 times. The company will use the IPO proceeds for debt repayment, working capital, and acquisitions. Revenue grew 14% in FY24, while profits saw a decline.

More To Explore

Private Banks, Pharma, IT to thrive in 2025 amidst market volatility: Sumit Bhatnagar

One obviously is the Trump presidency. He is the most unpredictable man and leading a $30 trillion economy, the world’s most powerful country, adds a

December 27, 2024

Animal feed business to maintain strong margins despite high commodity prices: Nadir B Godrej

We expect good margins in the animal feed sector. We have invested a lot in R&D for animal feed. It makes the feed lower cost

December 27, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003